Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetaminophen vs Ibuprofen for Recurrent Aphthous Ulcers in Pediatric Celiac Disease
NCT06149507Phase 4Not yet recruiting
- Sponsor
- Cairo University
- Start
- Mar 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of acetaminophen in Recurrent aphthous stomatitis (RAS) (2 arms), sponsored by Cairo University. Primary endpoint: Change in pain intensity at 6 months. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
acetaminophen
03
Conditions
Recurrent aphthous stomatitis (RAS)
Beyond the preview
Go deeper on NCT06149507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06149507.